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ABSTRACT:
The liver is an important organ of the human body, playing a major role in the metabolism 
and storage of nutrients, synthesis of protein and other nutrients, as well as detoxifying many 
metabolic by-products. The response of the foetal and newborn liver to external insult and injury 
is limited. This is because the ability of the closely interdependent structures of a developing 
liver of expressing in the face of a variety of insults is limited as well. Thus most infants with 
insults to the liver present as cholestatic jaundice with variable degree of pale stools, enlarged 
liver and conjugated hyperbilirubinaemia. Biliary atresia, an idiopathic condition characterized by 
progressive fibrosing obliteration of both intra- and extrahepatic bile ducts, is the most important 
cause of neonatal cholestasis worldwide, including Malaysia. It is also the most important 
indication for childhood liver transplantation the world over. Challenges facing infants with 
biliary atresia include a delay in the diagnosis and late surgery, leading to a poor outcome. This 
often results from a failure to recognise the potential serious nature of an infant with prolonged 
cholestatic jaundice and pale stools among health care professionals. (JUMMEC 2010; 13(2): 72-79)
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Introduction
The liver is the largest organ of the human body. It 
weighs approximately 2 to 2.5% of the total body 
weight of a healthy adult. The liver plays a major role 
in the metabolism and storage of nutrients, synthesis 
of various proteins and coagulation factors, as well as 
detoxifying many metabolic by-products (1).
Embryology of the liver
In the human embryo, the liver is derived from the 
endoderm, one of the three germ layers formed from 
gastrulation (2). It first appears as a hollow endodermal 
bud derived from the foregut. Hepatoblasts, the 
progenitor of liver cells, derived entirely from this 
budding endoderm, are identifiable from about 
28 days (2). The vascular sinusoidal network of the 
embryonic liver is derived from the mesodermal layer. 
Bile ducts are derived from two distinct elements. 
Intrahepatic bile ducts appear from about seven weeks 
while the extrahepatic bile ducts are derived from the 
budding foregut endoderm (2). The weight of the liver 
of a newborn is approximately 200g, ~ 5% of the body 
mass. This is very small compared to the liver of a full 
grown adult which weighs approximately 1.2-1.8 kg (2). 
The main driving force in the generation of bile flow 
in early life is the hepatocyte secretion of bile acids. 
There are evidences to suggest that there is a period of 
‘physiological cholestasis’ associated with immature or 
altered metabolism and transport of bile acids at birth 
(3). This may be due to a combination of structural 
and functional immaturity of the hepatic excretory 
functions in the newborns (4).
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Neonatal cholestasis
The response of the foetal and newborn liver to insult 
and injury is limited. This is because the ability of the 
closely interdependent structures of a developing 
liver, i.e. hepatocytes, small intrahepatic bile 
ductules, large extrahepatic bile ducts, of expressing 
in the face of a variety of insults is limited as well 
(5). Injury to the newborn liver usually manifests 
as neonatal cholestasis. Clinically, this manifests 
as variable degree of pale stools and enlarged 
liver, and biochemically as prolonged conjugated 
hyperbilirubinaemia (6, 7). 
Causes and clinical features of neonatal 
cholestasis
Many causes have been identified to cause injury to 
the newborn liver (8, 9). These may include intrahepatic 
causes, which may be either sporadic or familial, and 
extrahepatic causes (8). In the 146 cases of neonatal 
cholestasis referred to the Paediatric Unit of University 
of Malaya Medical Centre (UMMC), Kuala Lumpur, 
approximately 30% of cases were eventually found to 
have biliary atresia (BA, Table 1) (8-10). 
Most of the infants with liver injury present 
ascholestatic jaundice with variable degree of pale 
stools and enlarged liver (7). There are considerable 
overlap in the clinical features of various cause of 
neonatal cholestasis (Table 2) (7, 11). Jaundice is a 
universal clinical features of neonatal cholestasis (7). 
However, there is no evidence to suggest that infants 
with BA have an earlier onset or more severe degree 
of jaundice than those with other causes of neonatal 
cholestasis (11). In addition, it is also impossible 
to differentiate the underlying cause of neonatal 
cholestasis based on the size of hepatomegaly (11). 
Hence, it is important to realise that each of the 
presenting features of neonatal liver disease is an 
imperfect way of discerning the underlying cause of the 
cholestasis. It is always a challenge for paediatricians 
to identify the underlying cause of the insult to liver 
even though their clinical manifestations may be very 
similar (7, 12).
Importance of early diagnosis
The majority of infants with cholestatic liver disease 
present during the first month of life (13). Thus, prompt 
and efficient differentiation of cholestatic jaundice 
from common physiological hyperbilirubinaemia of 
the neonate or the prolonged jaundice occasionally 
associated with breast feeding is essential (14). This 
is because in BA, when hepatoportoenterostomy is 
Table 1: Major causes of neonatal cholestasis seen at the University of Malaya Medical Centre, Kuala Lumpur; 1996 – 2004
Underlying causes N %
Bile duct obstruction 
Biliary atresia 42 29
Other causes 4 3
Infections
Idiopathic 56 38
Cytomegalovirus 13 9
Other infections 5 3
Progressive familial intrahepatic cholestasis 5 3
Endocrine causes 5 3
Metabolic causes 3 2
Acute liver failure 4 3
Parenteral nutrition-related cholestasis 7 5
Perinatal asphyxia 2 1
Total (%) 146 100
Adapted from: Lee WS, et al. Aetiology and outcome of neonatal cholestasis in Malaysia. Singapore Med J 2010; 51: 434-439.
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performed before 60 days of age, the percentage 
of infants with bile flow is between 67% and 82% 
(15, 16). This is reduced to 45-62% if the surgery is 
performed after 60 days (15, 16). However, a delay 
in the referral of infants with neonatal cholestasis 
for appropriate investigations and management 
remains common (12, 17). 
Reasons for delayed referral and diagnosis
Failure to realise this overlapping clinical features 
has often lead to delayed referral, diagnosis and 
appropriate management (Table 3) (12). In UMMC, 
the median age of referral for infants with neonatal 
cholestasis was 59 days (7). Factors contributing to a 
delay in referral included repeated false reassurance 
about the benign nature of neonatal cholestasis by 
medical and para-medical staffs, failure of hospital 
services, and parental refusal for referral (12).
Liver histology in neonatal cholestasis
Many biochemical and radiological methods are 
available to differentiate obstructive from non-
obstructive causes of neonatal cholestasis, though 
none are perfect (11). Histological examination of 
the biopsy materials obtained from infants with 
neonatal cholestasis has been found to be highly 
specific and sensitive in differentiating BA from other 
non-obstructing causes (11, 18). Liver biopsy can 
Table 2: Clinical features of neonatal cholestasis seen at the University of Malaya Medical Centre, Kuala Lumpur; 1996 – 2004
All causes
(n=146)
N (%)
Biliary atresia
(n=35)
N (%)
Other diagnoses
(n=111)
N (%)
Jaundice 146 (100) 35 (100) 111 (100)
Enlarged liver 139 (95) 35 (100) 104 (94)
Enlarged spleen 76 (52) 18 (51) 58 (52)
Colour of stools
Pigmented 44 (30) 2 (6) 42 (38)
Slightly pale 33 (22) 4 (11) 29 (26)
Pale 69 (47) 29 (83) 40 (36)
Adapted from: Lee WS, et al. Clinical features di! erentiating biliary atresia from other causes of neonatal cholestasis. Annals Acad Med 
Singapore 2010; 39: 648-654.
Factors n %
Repeated reassurances by primary health care staffs 17 26
Failure of medical services at referring hospital 7 11
No actions on blood investigations 1
Delayed review of nuclear medicine scan 1
Failed percutaneous cholangiogram 1
Inconclusive liver biopsy 1
Liver biopsy results unavailable for review 1
Incorrect diagnosis 2
Reluctance of parents for referral 5 8
Appropriate action / referral 8 55
Adapted from: Lee WS. Pre-admission consultation and late referral in infants with neonatal cholestasis. J Paediatr Child Health 2008; 
44: 57-61.
Table 3: Factors contributing to delayed referral in 65 infants with neonatal cholestasis seen at University of Malaya Medical 
Centre, Kuala Lumpur
75
REVIEW JUMMEC 2010: 13(2)
be performed safely even in the smallest of infants 
(11, 18). Bile ductular proliferation, bile plugging, 
multinucleated giant cells, focal necrosis of the 
parenchyma, extramedullary haemopoiesis and 
inflammatory cell infiltrate in the portal area are 
all well-recognised histological features of BA (18). 
Most of these features are more commonly seen in 
older infants with BA with advanced stages of biliary 
cirrhosis (19).
However, it should be remembered that the 
histological features of biliary atresia is dynamic. 
There remains considerable overlap in the histological 
features of BA and other non-obstructive causes 
of neonatal cholestasis (Table 4) (20). Early in life, 
characteristic features of obstruction may not be 
obvious (Figures 1 & 2) (20). The staining of the liver 
biopsy tissue with a special stain for biliary epithelium 
helps to make an accurate diagnosis of biliary atresia 
(Figure 3) (21).
Scoring system in the interpretation of histology 
in neonatal cholestasis
Because of the non-specific nature of the histology 
in cholestatic neonatal liver disease, many authors 
Table 4: Histological features of neonatal cholestasis (Brough & Bernstein, 1969) 
Biliary atresia (n=58)
Major features Bile ductular proliferation (100%)
Minor features Portal fibrosis (47%)
Bile plugs in dilated ducts (40%)
Giant cell transformation (25%)
Portal and/or lobular inflammatory infiltrate (28%)
Neonatal hepatitis (n=29)
Major features Hepatocellular damage and hepatitis (100%)
Minor features Giant cell transformation (variable)
Bile ductular proliferation (14%)*
Bile stasis (almost exclusively intracellular and canalicular)
Portal fibrosis – slight
* Bile ductular proliferation was generally mild and was focally or irregularly distributed. In addition, the distortion and irregularity of 
the proliferating ducts, characteristically seen in biliary atresia, were lacking. 
Adapted from: Brough AJ and Bernstein J. Liver biopsy in the diagnosis of infantile obstructive jaundice. Pediatrics 1969; 43: 519-526.
Table 5: Outcome of 57 children with biliary atresia referred to University Malaya Medical Centre, Kuala Lumpur; 1996 – 2004
n %
Alive, no morbidity 16 28
Alive, major morbidity 5 9
Alive, liver transplant 2 4
Died, without surgery 9 16
Died, unsuccessful surgery 23 40
Died, after liver transplant 2 4
Total 57 100
Adapted from: Lee WS, et al. Outcome of biliary atresia in Malaysia. J Paediatr Child Health 2009.
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Figure 2: Liver biopsy of the same patient obtained at 45 days of age
A portal tract was shown here with marked bile ductular proliferation, and bile plug in bile ductules, typical of biliary atresia (H&E, 
x 200).
Adapted from: Lee WS, et al. Diagnostic usefulness of a 7-feature, 15-point scoring system in the interpretation of liver histology 
in neonatal cholestasis. World J Gastroenterol 2009.
Figure 1: Liver biopsy of a patient with biliary atresia obtained at 34 days of age
A portal tract was shown here with no obvious bile ductular proliferation. There was hepatocytic degeneration and swelling (H&E, x 
200).
Adapted from: Lee WS, et al. Diagnostic usefulness of a 7-feature, 15-point scoring system in the interpretation of liver histology 
in neonatal cholestasis. World J Gastroenterol 2009.
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have attempted to devise various histological scoring 
systems. The scoring system devised by Zerbini et al 
suffered from being too complex (22), and has not 
been adopted widely.
A histology scoring system was devised at the 
Department of Paediatrics, UMMC, based on 7-feature 
(portal ductal proliferation, bile plugs in the ductules, 
porto-portal bridging, lymphocytic infiltration in 
the portal region, multinucleated hepatocytes, 
neutrophilic infiltration, hepatocellular swelling), 
15-scoring (0-15) scoring system (21). With this system, 
Lee and Looi reviewed blindly 84 liver biopsy specimens 
obtained from 78 infants with neonatal cholestasis. 
A score of 7 was found to have the best overall 
diagnostic utility to differentiate BA from other 
intrahepatic cholestasis histologically (sensitivity for 
BA 88%, specificity 94% and accuracy 92%) (21). 
Biliary atresia
BA is an idiopathic condition characterised by 
progressive fibrosing obliteration of both intra- and 
extrahepatic bile ducts (23). It is the most important 
cause of neonatal cholestasis worldwide, including 
Malaysia (10, 23). It is also the most important 
indication for childhood liver transplantation the 
world over (24). The main challenges facing infants 
and children with BA in Malaysia is late surgery leading 
to a poor outcome (Table 5) (10, 12). 
Outcome of biliary atresia in UMMC, Malaysia
The outcome of infants with BA with unsuccessful 
surgery is poor (23). Without liver transplantation, the 
median age of survival was 15 months (23). In those with 
unsuccessful surgery, liver transplantation is essential to 
ensure long term survival. In the United Kingdom, where 
surgery for BA is centralized to three regional centres, 
the 4-year actuarial survival (with liver transplantation) 
was 89%, while the 4-year actuarial survival with 
native liver was 51% (25). In UMMC, a study involving 
57 infants with BA from 1996 to 2005 showed that the 
2-year actuarial survival (with liver transplantation) 
was 40%, while the 2-year actuarial survival with native 
liver was 37% (10). 
Figure 3: Liver biopsy stained with MnF116 in biliary atresia showing a portal tract with marked bile ductular proliferation
Marked bile ductular proliferation with tortuosity within a portal tract (MnF116, x 200).
Adapted from: Lee WS, et al. Diagnostic usefulness of a 7-feature, 15-point scoring system in the interpretation of liver histology 
in neonatal cholestasis. World J Gastroenterol 2009.
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Two factors contributed to the poorer surgical 
outcome and actuarial survival for BA in UMMC as 
compared to other more advanced countries in 
the world. They are a delay in referral for infants 
with neonatal cholestasis for appropriate diagnosis 
and surgery for BA, as well as limited availability 
of liver transplantation in children who have end 
stage liver failure in Malaysia (10). Nevertheless, the 
survival rate with native liver in children with BA 
operated at UMMC is comparable to other countries in 
the world (Table 6) (10).
Future challenges 
The challenges of neonatal cholestasis and BA in 
Malaysia are manifold. Firstly, health care providers 
need to be aware of the potentially serious nature 
of an infant with prolonged cholestatic jaundice and 
pale stools. Obstructive causes need to be excluded 
in the first instance. Secondly, infants suspected 
of having BA should be managed in a centre with 
appropriate medical and surgical expertise. Finally, 
liver transplantation service in Malaysia should be 
expanded so that more children with end stage liver 
failure can receive life-saving surgery.
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